Skip to main content
eScholarship
Open Access Publications from the University of California

Lessons from the CAGI-4 Hopkins clinical panel challenge

  • Author(s): Chandonia, JM
  • Adhikari, A
  • Carraro, M
  • Chhibber, A
  • Cutting, GR
  • Fu, Y
  • Gasparini, A
  • Jones, DT
  • Kramer, A
  • Kundu, K
  • Lam, HYK
  • Leonardi, E
  • Moult, J
  • Pal, LR
  • Searls, DB
  • Shah, S
  • Sunyaev, S
  • Tosatto, SCE
  • Yin, Y
  • Buckley, BA
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600166/
No data is associated with this publication.
Abstract

© 2017 Wiley Periodicals, Inc. The CAGI-4 Hopkins clinical panel challenge was an attempt to assess state-of-the-art methods for clinical phenotype prediction from DNA sequence. Participants were provided with exonic sequences of 83 genes for 106 patients from the Johns Hopkins DNA Diagnostic Laboratory. Five groups participated in the challenge, predicting both the probability that each patient had each of the 14 possible classes of disease, as well as one or more causal variants. In cases where the Hopkins laboratory reported a variant, at least one predictor correctly identified the disease class in 36 of the 43 patients (84%). Even in cases where the Hopkins laboratory did not find a variant, at least one predictor correctly identified the class in 39 of the 63 patients (62%). Each prediction group correctly diagnosed at least one patient that was not successfully diagnosed by any other group. We discuss the causal variant predictions by different groups and their implications for further development of methods to assess variants of unknown significance. Our results suggest that clinically relevant variants may be missed when physicians order small panels targeted on a specific phenotype. We also quantify the false-positive rate of DNA-guided analysis in the absence of prior phenotypic indication.

Item not freely available? Link broken?
Report a problem accessing this item